Re-specification of the Antibiotic Utilization Healthcare Effectiveness Data and Information Set (HEDIS)

The Centers for Disease Control and Prevention seeks to revise the Antibiotic Utilization Healthcare Effectiveness Data and Information Set measure through a re-specification of the measure to focus specifically on acute respiratory infections. The solicitation issued by the CDC Office of Acquisition Services requires the contractor to revise the current measure, convene a stakeholder panel, obtain approval from the National Committee for Quality Assurance, and finalize and update the revised measure for inclusion in HEDIS. Questions are due by April 10, 2020, and proposals are due by May 7, 2020, with the period of performance running from June 1, 2020 through May 31, 2022. Evaluation criteria include technical approach, staff qualifications, and past performance.

There is no set-aside designation specified. The place of performance is within the United States. The solicitation does not provide budget ranges or potential award values. Services must be completed by May 31, 2022, with revisions to the measure focusing on acute respiratory infections and re-specifying it as an episode-based measure.